A better understanding of immune response variations provides insight into whether and how much protection vaccination will provide against the Mu variant.
WEDNESDAY, Sept. 28, 2022 (HealthDay) Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer s disease.
A US neuroscientist claims that some of the studies of the experimental agent, Simufilam, a drug that targets amyloid beta in Alzheimer s disease, are flawed and has taken his concerns to the NIH.
A novel, disease-modifying therapy for Alzheimer's disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice, according to a new study from UTHealth Houston.
Researchers using whole blood exchange were able to reduce the formation of amyloid plaque in the brains of mice, which may offer a therapy for Alzheimer’s.